Romania

Institutul National De Cercetare - Dezvoltare Pentru Microbiologie Si Imunologie "Cantacuzino"

An EMIS Company Report EMIS is a Euromoney Institutional Investor plc company USD 19.99 Industry: Research and Development in the Physical, Engineering, and Life Sciences Available in: English & Romanian Format: PDF Download Most recent financial data: 2014 Buy full report

What’s included?

This report extracts all available information about Institutul National De Cercetare - Dezvoltare Pentru Microbiologie Si Imunologie "Cantacuzino" from EMIS' database of company information. The Table of Contents on the right indicates the categories of information that will be included in your report upon purchase.

Download a sample report

Company Tear Sheet (locked content will be provided in the purchased report)

Contact Information

Headquarters
Spl. Independentei, Nr. 103, Sect. 5
Bucharest; Bucharest; Map
Postal Code: 050096

Tel: +40 215 287 ; +40 215 287

Company Description
National Institute of Research and Development for Microbiology and Immunology "Cantacuzino" (INCDMI "Cantacuzino") is a research institute in Romania, founded in 1921. Institute's field of activity is public health, which promotes both the research development and by offering products and services. Scientific research, technological development and innovation are conducted in the areas of bacterial, viral and parasitic cellular and molecular biology, immunology, biotechnology and microbial genetics. Cantacuzino Institute currently has the strongest basic research techniques in microbiology, molecular epidemiology and immunology of the country and that is significant as compared with those internationally.
NAICS Industry Classification
Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Basic Information
Total Employees:
435 (2015)
Registered Capital:
()
Incorporation Date:
February 12, 2003
Profile Updated:
August 28, 2017
Key Executives
General Manager
Administrator
Ownership Details
Ministry of Education
100%
Key Financial Highlights
2015 Q2C
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets 298,327
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Individual
Source: Creditinfo Romania, EMIS Company Database.
Financial Performance Charts
Top Competitors

Financial Statements

Annual Statements

EMIS Credit Analytics

EMIS Benchmark Score
Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

REQUEST A DEMO

To view more information, REQUEST A DEMO